115 related articles for article (PubMed ID: 24787960)
21. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of nuclear matrix proteins during HMBA-induced differentiation of gastric cancer cells.
Jing GJ; Xu DH; Shi SL; Li QF; Wang SY; Wu FY; Kong HY
World J Gastroenterol; 2010 May; 16(17):2176-82. PubMed ID: 20440860
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network.
Castelli M; Pieroni S; Brunacci C; Piobbico D; Bartoli D; Bellet MM; Colombo E; Pelicci PG; Della Fazia MA; Servillo G
Oncogene; 2013 Jul; 32(28):3350-8. PubMed ID: 22890319
[TBL] [Abstract][Full Text] [Related]
25. Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.
Léotoing L; Meunier L; Manin M; Mauduit C; Decaussin M; Verrijdt G; Claessens F; Benahmed M; Veyssière G; Morel L; Beaudoin C
Oncogene; 2008 May; 27(20):2858-67. PubMed ID: 18037965
[TBL] [Abstract][Full Text] [Related]
26. Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability.
Xiao J; Zhang Z; Chen GG; Zhang M; Ding Y; Fu J; Li M; Yun JP
Cell Cycle; 2009 Mar; 8(6):889-95. PubMed ID: 19221506
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
Li J; Zhang X; Sejas DP; Pang Q
Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
[TBL] [Abstract][Full Text] [Related]
28. Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
Brodská B; Kráčmarová M; Holoubek A; Kuželová K
PLoS One; 2017; 12(4):e0175175. PubMed ID: 28384310
[TBL] [Abstract][Full Text] [Related]
29. Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6.
Liu GY; Shi JX; Shi SL; Liu F; Rui G; Li X; Gao LB; Deng XL; Li QF
J Cell Biochem; 2017 Dec; 118(12):4697-4707. PubMed ID: 28513872
[TBL] [Abstract][Full Text] [Related]
30. [Localization of prohibitin in nuclear matrix and its expressive alteration during the differentiation of human osteosarcoma MG-63 cells induced by HMBA].
Li QF; Zhao CH; Tang J; Liu QR; Shi SL
Fen Zi Xi Bao Sheng Wu Xue Bao; 2008 Feb; 41(1):1-10. PubMed ID: 18464584
[TBL] [Abstract][Full Text] [Related]
31. [Nucleophosmin mutations in hematological malignancies - review].
Luo ZP; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889
[TBL] [Abstract][Full Text] [Related]
32. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal half of NPM dissociates from nucleoli of HeLa cells after anticancer drug treatments.
Chan PK; Bloom DA; Hoang TT
Biochem Biophys Res Commun; 1999 Oct; 264(1):305-9. PubMed ID: 10527882
[TBL] [Abstract][Full Text] [Related]
35. Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells.
Zhang Y; Owusu L; Duan W; Jiang T; Zang S; Ahmed A; Xin Y
Int J Mol Med; 2013 Oct; 32(4):959-64. PubMed ID: 23863984
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin and human cancer.
Lim MJ; Wang XW
Cancer Detect Prev; 2006; 30(6):481-90. PubMed ID: 17113241
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
38. ATP depletion affects NPM translocation and exportation of rRNA from nuclei.
Finch RA; Chan PK
Biochem Biophys Res Commun; 1996 May; 222(2):553-8. PubMed ID: 8670243
[TBL] [Abstract][Full Text] [Related]
39. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
[TBL] [Abstract][Full Text] [Related]
40. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
